Why Study Infant Formula?
JBR Clinical Research is currently seeking expectant mothers to participate in a clinical study to evaluate the safety and effectiveness of a low lactose infant formula. Low-lactose formula is a cow’s milk-based formula that has the sugar, lactose, removed and replaced with glucose polymers. Those eligible to participate must be healthy, full term newborns.
The ideal source of food for newborns is breast milk. However, there are many circumstances when it difficult or not an option for mothers to breastfeed. When mothers cannot or do not plan to breastfeed for whatever reason, infant formulas are a safe and healthy alternative.
Infant formulas are manufactured using strict hygiene standards and formulated according to recognized nutritional standards. Research and development in infant formulas is an extensive and complex process, as the infant food industry is continually studying and developing better formulas. The process involves many specialists including nutritionists, pediatricians, dieticians, food technologists, microbiologists, toxicologists and experts in regulatory affairs.
There are several stages in research and development. First, researchers must identify a particular nutritional need in infants and young children. For instance, infants who are sensitive to lactose and are experiencing feeding problems like fussiness, crying, bloating, gas, or diarrhea. Researchers must then design a product to meet that need, source the right ingredients, manufacture a prototype product and conduct clinical studies in this age group.
Clinical studies are conducted to evaluate the effectiveness of infant formula before it is made available to the public. Infants who are selected to participate in the JBR Clinical Research clinical study will receive low lactose infant formula, health care related to the study and compensation up to $350 for time and travel.
We invite you to read more information about the infant formula clinical research qualifications or to sign up for the infant formula study. You may also call JBR Clinical Research at 801-261-2000.